Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Celecoxib/Pregabalin/Vitamin B FDC in Chronic Low Back Pain
NCT06516094Phase 3Completed
- Sponsor
- Laboratorios Silanes
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution, pregabalin, thiamine, pyridoxine, cyanocobalamin in chronic low back pain (CLBP), sponsored by Laboratorios Silanes. Started Apr 2024; status: completed.
02
Drugs
celecoxib oral solutionpregabalinthiaminepyridoxinecyanocobalamin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT06516094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06516094.